Dunvegan Associates’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q4 | $1.75M | Sell |
15,471
-1,038
| -6% | -$117K | 2.05% | 13 |
|
|
2015
Q3 | $1.67M | Sell |
16,509
-150
| -0.9% | -$15.2K | 1.9% | 14 |
|
|
2015
Q2 | $2.05M | Sell |
16,659
-5,973
| -26% | -$735K | 2.27% | 14 |
|
|
2015
Q1 | $2.59M | Sell |
22,632
-546
| -2% | -$62.5K | 2.29% | 13 |
|
|
2014
Q4 | $2.34M | Sell |
23,178
-972
| -4% | -$98.3K | 2.04% | 17 |
|
|
2014
Q3 | $2.2M | Sell |
24,150
-84
| -0.3% | -$7.66K | 1.99% | 17 |
|
|
2014
Q2 | $2.08M | Sell |
24,234
-237
| -1% | -$20.3K | 1.73% | 19 |
|
|
2014
Q1 | $1.93M | Sell |
24,471
-3,267
| -12% | -$257K | 1.62% | 22 |
|
|
2013
Q4 | $2.1M | Sell |
27,738
-6,159
| -18% | -$466K | 1.73% | 19 |
|
|
2013
Q3 | $2.37M | Sell |
33,897
-1,248
| -4% | -$87.2K | 1.75% | 21 |
|
|
2013
Q2 | $2.04M | Buy |
+35,145
| New | +$2.04M | 1.57% | 24 |
|